{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:08:53Z","timestamp":1776276533668,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00393-024-01493-z","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T16:01:42Z","timestamp":1710777702000},"page":"217-228","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Update Sj\u00f6gren-Syndrom","Update on Sj\u00f6gren\u02bcs syndrome"],"prefix":"10.1007","volume":"83","author":[{"given":"Nadine","family":"Zehrfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"issue":"9","key":"1493_CR1","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1136\/annrheumdis-2021-219942","volume":"80","author":"R Jonsson","year":"2021","unstructured":"Jonsson\u00a0R (2021) Henrik sj\u00f6gren (1899\u20131986): The syndrome and his legacy. Ann Rheum Dis 80(9):1108\u20131109. https:\/\/doi.org\/10.1136\/annrheumdis-2021-219942","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1493_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini\u00a0S, Emmi\u00a0G, Greco\u00a0M et\u00a0al (2022) Sj\u00f6gren\u2019s syndrome: A\u00a0systemic autoimmune disease. Clin Exp Med 22(1):9\u201325. https:\/\/doi.org\/10.1007\/s10238-021-00728-6","journal-title":"Clin Exp Med"},{"issue":"9","key":"1493_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00393-022-01305-2","volume":"82","author":"K Albrecht","year":"2023","unstructured":"Albrecht\u00a0K, Binder\u00a0S, Minden\u00a0K et\u00a0al (2023) Systematic review to estimate the prevalence of inflammatory rheumatic diseases in germany. german version. Z\u00a0Rheumatol 82(9):727\u2013738. https:\/\/doi.org\/10.1007\/s00393-022-01305-2","journal-title":"Z Rheumatol"},{"issue":"11","key":"1493_CR4","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","volume":"74","author":"B Qin","year":"2015","unstructured":"Qin\u00a0B, Wang\u00a0J, Yang\u00a0Z et\u00a0al (2015) Epidemiology of primary sj\u00f6gren\u2019s syndrome: A\u00a0systematic review and meta-analysis. Ann Rheum Dis 74(11):1983\u20131989. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205375","journal-title":"Ann Rheum Dis"},{"key":"1493_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.clim.2016.04.002","volume":"168","author":"VM Harris","year":"2016","unstructured":"Harris\u00a0VM, Sharma\u00a0R, Cavett\u00a0J et\u00a0al (2016) Klinefelter\u2019s syndrome (47,XXY) is in excess among men with sj\u00f6gren\u2019s syndrome. Clin Immunol 168:25\u201329. https:\/\/doi.org\/10.1016\/j.clim.2016.04.002","journal-title":"Clin Immunol"},{"issue":"4","key":"1493_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/art.1780360407","volume":"36","author":"H Foster","year":"1993","unstructured":"Foster\u00a0H, Stephenson\u00a0A, Walker\u00a0D, Cavanagh\u00a0G, Kelly\u00a0C, Griffiths\u00a0I (1993) Linkage studies of HLA and primary sj\u00f6gren\u2019s syndrome in multicase families. Arthritis Rheum 36(4):473\u2013484. https:\/\/doi.org\/10.1002\/art.1780360407","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1493_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/rheumatology\/31.5.309","volume":"31","author":"H Foster","year":"1992","unstructured":"Foster\u00a0H, Walker\u00a0D, Charles\u00a0P, Kelly\u00a0C, Cavanagh\u00a0G, Griffiths\u00a0I (1992) Association of DR3 with susceptibility to and severity of primary sj\u00f6gren\u2019s syndrome in a\u00a0family study. Br J Rheumatol 31(5):309\u2013314. https:\/\/doi.org\/10.1093\/rheumatology\/31.5.309","journal-title":"Br J Rheumatol"},{"issue":"1","key":"1493_CR8","doi-asserted-by":"publisher","first-page":"6519","DOI":"10.1038\/s41467-022-34311-8","volume":"13","author":"B Khatri","year":"2022","unstructured":"Khatri\u00a0B, Tessneer\u00a0KL, Rasmussen\u00a0A et\u00a0al (2022) Author correction: Genome-wide association study identifies sj\u00f6gren\u2019s risk loci with functional implications in immune and glandular cells. Nat Commun 13(1):6519\u20136518. https:\/\/doi.org\/10.1038\/s41467-022-34311-8","journal-title":"Nat Commun"},{"issue":"24","key":"1493_CR9","doi-asserted-by":"publisher","first-page":"e166540","DOI":"10.1172\/jci.insight.166540","volume":"8","author":"Y Shen","year":"2023","unstructured":"Shen\u00a0Y, Voigt\u00a0A, Goranova\u00a0L et\u00a0al (2023) Evidence of a\u00a0sj\u00f6gren\u2019s disease-like phenotype following COVID-19 in mice and humans. JCI Insight 8(24):e166540. https:\/\/doi.org\/10.1172\/jci.insight.166540","journal-title":"JCI Insight"},{"issue":"9","key":"1493_CR10","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1002\/art.20463","volume":"50","author":"A Triantafyllopoulou","year":"2004","unstructured":"Triantafyllopoulou\u00a0A, Tapinos\u00a0N, Moutsopoulos\u00a0HM (2004) Evidence for coxsackievirus infection in primary sj\u00f6gren\u2019s syndrome. Arthritis Rheum 50(9):2897\u20132902. https:\/\/doi.org\/10.1002\/art.20463","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1493_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1191\/0961203306lu2290rr","volume":"15","author":"DI Mitsias","year":"2006","unstructured":"Mitsias\u00a0DI, Kapsogeorgou\u00a0EK, Moutsopoulos\u00a0HM (2006) The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: Lessons from sjogren\u2019s syndrome (autoimmune epithelitis). Lupus 15(5):255\u2013261. https:\/\/doi.org\/10.1191\/0961203306lu2290rr","journal-title":"Lupus"},{"issue":"9894","key":"1493_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","volume":"382","author":"M Wahren-Herlenius","year":"2013","unstructured":"Wahren-Herlenius\u00a0M, D\u00f6rner\u00a0T (2013) Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382(9894):819\u2013831. https:\/\/doi.org\/10.1016\/S0140-6736(13)60954-X","journal-title":"Lancet"},{"issue":"9","key":"1493_CR13","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/art.42238","volume":"74","author":"SS McCoy","year":"2022","unstructured":"McCoy\u00a0SS, Woodham\u00a0M, Bartels\u00a0CM et\u00a0al (2022) Symptom-based cluster analysis categorizes sj\u00f6gren\u2019s disease subtypes: An international cohort study highlighting disease severity and treatment discordance. Arthritis Rheumatol 74(9):1569\u20131579. https:\/\/doi.org\/10.1002\/art.42238","journal-title":"Arthritis Rheumatol"},{"key":"1493_CR14","doi-asserted-by":"publisher","first-page":"e3821","DOI":"10.1136\/bmj.e3821","volume":"344","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals\u00a0M, Brito-Zer\u00f3n\u00a0P, Sis\u00f3-Almirall\u00a0A, Bosch\u00a0X (2012) Primary sjogren syndrome. BMJ 344:e3821. https:\/\/doi.org\/10.1136\/bmj.e3821","journal-title":"BMJ"},{"key":"1493_CR15","doi-asserted-by":"publisher","first-page":"777599","DOI":"10.3389\/fmed.2021.777599","volume":"8","author":"E Kramer","year":"2021","unstructured":"Kramer\u00a0E, Seeliger\u00a0T, Skripuletz\u00a0T et\u00a0al (2021) Multimodal assessment and characterization of sicca syndrome. Front Med 8:777599. https:\/\/doi.org\/10.3389\/fmed.2021.777599","journal-title":"Front Med"},{"key":"1493_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fmed.2020.00332","volume":"7","author":"G Sogkas","year":"2020","unstructured":"Sogkas\u00a0G, Hirsch\u00a0S, Olsson\u00a0KM et\u00a0al (2020) Lung involvement in primary sj\u00f6gren\u2019s syndrome\u2014an under-diagnosed entity. Front Med 7:332. https:\/\/doi.org\/10.3389\/fmed.2020.00332","journal-title":"Front Med"},{"issue":"7","key":"1493_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00393-020-00821-3","volume":"79","author":"T Thiele","year":"2020","unstructured":"Thiele\u00a0T, Seeliger\u00a0T, Witte\u00a0T, Sander\u00a0B, Skripuletz\u00a0T, Ernst\u00a0D (2020) Severe polyneuropathy in primary sj\u00f6gren\u2019s syndrome : Sj\u00f6gren\u2019s syndrome should be considered in patients with motor neuropathy. Z\u00a0Rheumatol 79(7):707\u2013709. https:\/\/doi.org\/10.1007\/s00393-020-00821-3","journal-title":"Z Rheumatol"},{"issue":"8","key":"1493_CR18","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/acn3.51123","volume":"7","author":"T Seeliger","year":"2020","unstructured":"Seeliger\u00a0T, Jacobsen\u00a0L, Hendel\u00a0M et\u00a0al (2020) Cognitive impairment in patients with neuro-sj\u00f6gren. Ann Clin Transl Neurol 7(8):1352\u20131359. https:\/\/doi.org\/10.1002\/acn3.51123","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"1493_CR19","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1007\/s00415-023-11613-5","volume":"270","author":"T Seeliger","year":"2023","unstructured":"Seeliger\u00a0T, Kramer\u00a0E, Konen\u00a0FF et\u00a0al (2023) Sj\u00f6gren\u2019s syndrome with and without neurological involvement. J\u00a0Neurol 270(6):2987\u20132996. https:\/\/doi.org\/10.1007\/s00415-023-11613-5","journal-title":"J Neurol"},{"issue":"5","key":"1493_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","volume":"74","author":"R Seror","year":"2015","unstructured":"Seror\u00a0R, Theander\u00a0E, Brun\u00a0JG et\u00a0al (2015) Validation of EULAR primary sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 74(5):859\u2013866. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204615","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1493_CR21","first-page":"97","volume":"37 Suppl 118","author":"S Retamozo","year":"2019","unstructured":"Retamozo\u00a0S, Acar-Denizli\u00a0N, Rasmussen\u00a0A et\u00a0al (2019) Systemic manifestations of primary sj\u00f6gren\u2019s syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a\u00a0large international, multi-ethnic cohort of patients. clin Exp Rheumatol 37 Suppl 118(3):97\u2013106","journal-title":"clin Exp Rheumatol"},{"issue":"6","key":"1493_CR22","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/jpm13060961","volume":"13","author":"A Mihai","year":"2023","unstructured":"Mihai\u00a0A, Caruntu\u00a0C, Jurcut\u00a0C et\u00a0al (2023) The spectrum of extraglandular manifestations in primary sj\u00f6gren\u2019s syndrome. J\u00a0Pers Med 13(6):961. https:\/\/doi.org\/10.3390\/jpm13060961","journal-title":"J Pers Med"},{"issue":"7","key":"1493_CR23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3899\/jrheum.200733","volume":"48","author":"SS McCoy","year":"2021","unstructured":"McCoy\u00a0SS, Bartels\u00a0CM, Saldanha\u00a0IJ et\u00a0al (2021) National sj\u00f6gren\u2019s foundation survey: Burden of oral and systemic involvement on quality of life. J\u00a0Rheumatol 48(7):1029\u20131036. https:\/\/doi.org\/10.3899\/jrheum.200733","journal-title":"J Rheumatol"},{"key":"1493_CR24","doi-asserted-by":"publisher","first-page":"1048684","DOI":"10.3389\/fcvm.2022.1048684","volume":"9","author":"CL Zippel","year":"2022","unstructured":"Zippel\u00a0CL, Beider\u00a0S, Kramer\u00a0E et\u00a0al (2022) Premature stroke and cardiovascular risk in primary sj\u00f6gren\u2019s syndrome. Front Cardiovasc Med 9:1048684. https:\/\/doi.org\/10.3389\/fcvm.2022.1048684","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"1493_CR25","doi-asserted-by":"publisher","first-page":"e28062","DOI":"10.7759\/cureus.28062","volume":"14","author":"H Kaur","year":"2022","unstructured":"Kaur\u00a0H, Alazzeh\u00a0M, Thandavaram\u00a0A et\u00a0al (2022) Increased threat of thyroid diseases in patients with sjogren\u2019s syndrome: A\u00a0systematic review. Cureus 14(8):e28062. https:\/\/doi.org\/10.7759\/cureus.28062","journal-title":"Cureus"},{"issue":"1","key":"1493_CR26","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ophtha.2014.07.026","volume":"122","author":"EK Akpek","year":"2015","unstructured":"Akpek\u00a0EK, Mathews\u00a0P, Hahn\u00a0S et\u00a0al (2015) Ocular and systemic morbidity in a\u00a0longitudinal cohort of sj\u00f6gren\u2019s syndrome. Ophthalmology 122(1):56\u201361. https:\/\/doi.org\/10.1016\/j.ophtha.2014.07.026","journal-title":"Ophthalmology"},{"issue":"4","key":"1493_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/eos.12358","volume":"125","author":"S Rusthen","year":"2017","unstructured":"Rusthen\u00a0S, Young\u00a0A, Herlofson\u00a0BB et\u00a0al (2017) Oral disorders, saliva secretion, and oral health-related quality of life in patients with primary sj\u00f6gren\u2019s syndrome. Eur J Oral Sci 125(4):265\u2013271. https:\/\/doi.org\/10.1111\/eos.12358","journal-title":"Eur J Oral Sci"},{"issue":"3","key":"1493_CR28","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/rheumatology\/keac457","volume":"62","author":"I Minopoulou","year":"2023","unstructured":"Minopoulou\u00a0I, Pyrgidis\u00a0N, Tishukov\u00a0M et\u00a0al (2023) Sexual dysfunction in women with systemic autoimmune rheumatic disorders: A\u00a0systematic review and meta-analysis. Rheumatology 62(3):1021\u20131030. https:\/\/doi.org\/10.1093\/rheumatology\/keac457","journal-title":"Rheumatology"},{"issue":"5","key":"1493_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","volume":"53","author":"C Baldini","year":"2014","unstructured":"Baldini\u00a0C, Pepe\u00a0P, Quartuccio\u00a0L et\u00a0al (2014) Primary sjogren\u2019s syndrome as a\u00a0multi-organ disease: Impact of the serological profile on the clinical presentation of the disease in a\u00a0large cohort of italian patients. Rheumatology 53(5):839\u2013844. https:\/\/doi.org\/10.1093\/rheumatology\/ket427","journal-title":"Rheumatology"},{"issue":"2","key":"1493_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/joim.12346","volume":"278","author":"E Bartoloni","year":"2015","unstructured":"Bartoloni\u00a0E, Baldini\u00a0C, Schillaci\u00a0G et\u00a0al (2015) Cardiovascular disease risk burden in primary sj\u00f6gren\u2019s syndrome: Results of a\u00a0population-based multicentre cohort study. J\u00a0Intern Med 278(2):185\u2013192. https:\/\/doi.org\/10.1111\/joim.12346","journal-title":"J Intern Med"},{"key":"1493_CR31","doi-asserted-by":"crossref","unstructured":"Zehrfeld N, Benz S, Derda A et\u00a0al (2023) Pos1458 prevalence of subclinical atherosclerosis in patients with primary sj\u00f6gren\u2019s syndrome. 82(1083):1\u20131083","DOI":"10.1136\/annrheumdis-2023-eular.2606"},{"issue":"2","key":"1493_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/s-0034-1371529","volume":"35","author":"M Kreider","year":"2014","unstructured":"Kreider\u00a0M, Highland\u00a0K (2014) Pulmonary involvement in sj\u00f6gren syndrome. Semin Respir Crit Care Med 35(2):255\u2013264. https:\/\/doi.org\/10.1055\/s-0034-1371529","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"1493_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00296-022-05235-9","volume":"43","author":"V Paraschou","year":"2023","unstructured":"Paraschou\u00a0V, Partalidou\u00a0S, Siolos\u00a0P, Papadopoulou\u00a0Z, Chaitidis\u00a0N (2023) Prevalence of hearing loss in patients with sj\u00f6gren syndrome: A\u00a0systematic review and meta-analysis. Rheumatol Int 43(2):233\u2013244. https:\/\/doi.org\/10.1007\/s00296-022-05235-9","journal-title":"Rheumatol Int"},{"issue":"19","key":"1493_CR34","doi-asserted-by":"publisher","first-page":"12472","DOI":"10.3390\/ijerph191912472","volume":"19","author":"K B\u0142ochowiak","year":"2022","unstructured":"B\u0142ochowiak\u00a0K (2022) Smell and taste function and their disturbances in sj\u00f6gren\u2019s syndrome. Int J Environ Res Public Health 19(19):12472. https:\/\/doi.org\/10.3390\/ijerph191912472","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"1493_CR35","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/rheumatology\/keac470","volume":"62","author":"S De Vita","year":"2023","unstructured":"De Vita\u00a0S, Isola\u00a0M, Baldini\u00a0C et\u00a0al (2023) Predicting lymphoma in sj\u00f6gren\u2019s syndrome and the pathogenetic role of parotid microenvironment through precise parotid swelling recording. Rheumatology 62(4):1586\u20131593. https:\/\/doi.org\/10.1093\/rheumatology\/keac470","journal-title":"Rheumatology"},{"issue":"25","key":"1493_CR36","doi-asserted-by":"publisher","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","volume":"95","author":"S Fragkioudaki","year":"2016","unstructured":"Fragkioudaki\u00a0S, Mavragani\u00a0CP, Moutsopoulos\u00a0HM (2016) Predicting the risk for lymphoma development in sjogren syndrome: An easy tool for clinical use. Medicine 95(25):e3766. https:\/\/doi.org\/10.1097\/MD.0000000000003766","journal-title":"Medicine"},{"issue":"1","key":"1493_CR37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski\u00a0CH, Shiboski\u00a0SC, Seror\u00a0R et\u00a0al (2017) 2016 american college of rheumatology\/european league against rheumatism classification criteria for primary sj\u00f6gren\u2019s syndrome: A\u00a0consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69(1):35\u201345. https:\/\/doi.org\/10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"key":"1493_CR38","doi-asserted-by":"publisher","first-page":"581248","DOI":"10.3389\/fmed.2020.581248","volume":"7","author":"A Zabotti","year":"2020","unstructured":"Zabotti\u00a0A, Zandonella Callegher\u00a0S, Tullio\u00a0A et\u00a0al (2020) Salivary gland ultrasonography in sj\u00f6gren\u2019s syndrome: A\u00a0european multicenter reliability exercise for the HarmonicSS project. Front Med 7:581248. https:\/\/doi.org\/10.3389\/fmed.2020.581248","journal-title":"Front Med"},{"key":"1493_CR39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2147\/OARRR.S284763","volume":"14","author":"M Lorenzon","year":"2022","unstructured":"Lorenzon\u00a0M, Spina\u00a0E, Tulipano Di Franco\u00a0F, Giovannini\u00a0I, De Vita\u00a0S, Zabotti\u00a0A (2022) Salivary gland ultrasound in primary sj\u00f6gren\u2019s syndrome: Current and future perspectives. Open Access Rheumatol 14:147\u2013160. https:\/\/doi.org\/10.2147\/OARRR.S284763","journal-title":"Open Access Rheumatol"},{"issue":"4","key":"1493_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/jimaging8040111","volume":"8","author":"R Izzetti","year":"2022","unstructured":"Izzetti\u00a0R, Fulvio\u00a0G, Nisi\u00a0M, Gennai\u00a0S, Graziani\u00a0F (2022) Reliability of OMERACT scoring system in ultra-high frequency ultrasonography of minor salivary glands: Inter-rater agreement study. J\u00a0Imaging 8(4):111. https:\/\/doi.org\/10.3390\/jimaging8040111","journal-title":"J Imaging"},{"issue":"2","key":"1493_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/joim.12992","volume":"287","author":"S Jousse-Joulin","year":"2020","unstructured":"Jousse-Joulin\u00a0S, Gatineau\u00a0F, Baldini\u00a0C et\u00a0al (2020) Weight of salivary gland ultrasonography compared to other items of the 2016 ACR\/EULAR classification criteria for primary sj\u00f6gren\u2019s syndrome. J\u00a0Intern Med 287(2):180\u2013188. https:\/\/doi.org\/10.1111\/joim.12992","journal-title":"J Intern Med"},{"issue":"2","key":"1493_CR42","doi-asserted-by":"publisher","first-page":"e001516","DOI":"10.1136\/rmdopen-001516","volume":"7","author":"V Fana","year":"2021","unstructured":"Fana\u00a0V, Dohn\u00a0UM, Krabbe\u00a0S, Terslev\u00a0L (2021) Application of the OMERACT grey-scale ultrasound scoring system for salivary glands in a\u00a0single-centre cohort of patients with suspected sj\u00f6gren\u2019s syndrome. RMD Open 7(2):e1516. https:\/\/doi.org\/10.1136\/rmdopen-001516 (https:\/\/doi.org\/10.1136\/rmdopen-2020-001516)","journal-title":"RMD Open"},{"issue":"1","key":"1493_CR43","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/art.37698","volume":"65","author":"D Cornec","year":"2013","unstructured":"Cornec\u00a0D, Jousse-Joulin\u00a0S, Pers\u00a0J et\u00a0al (2013) Contribution of salivary gland ultrasonography to the diagnosis of sj\u00f6gren\u2019s syndrome: Toward new diagnostic criteria? Arthritis Rheum 65(1):216\u2013225. https:\/\/doi.org\/10.1002\/art.37698","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1493_CR44","first-page":"134","volume":"38 Suppl 126","author":"E Zampeli","year":"2020","unstructured":"Zampeli\u00a0E, Mavrommati\u00a0M, Moutsopoulos\u00a0HM, Skopouli\u00a0FN (2020) Anti-Ro52 and\/or anti-Ro60 immune reactivity: Autoantibody and disease associations. Clin Exp Rheumatol 38 Suppl 126(4):134\u2013141","journal-title":"Clin Exp Rheumatol"},{"key":"1493_CR45","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/fimmu.2019.00444","volume":"10","author":"A Robbins","year":"2019","unstructured":"Robbins\u00a0A, Hentzien\u00a0M, Toquet\u00a0S et\u00a0al (2019) Diagnostic utility of separate anti-Ro60 and anti-Ro52\/TRIM21 antibody detection in autoimmune diseases. Front Immunol 10:444. https:\/\/doi.org\/10.3389\/fimmu.2019.00444","journal-title":"Front Immunol"},{"issue":"20","key":"1493_CR46","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3238\/arztebl.2017.0354","volume":"114","author":"A Stefanski","year":"2017","unstructured":"Stefanski\u00a0A, Tomiak\u00a0C, Pleyer\u00a0U, Dietrich\u00a0T, Burmester\u00a0GR, D\u00f6rner\u00a0T (2017) The diagnosis and treatment of sj\u00f6gren\u2019s syndrome. Dtsch Arztebl Int 114(20):354\u2013361. https:\/\/doi.org\/10.3238\/arztebl.2017.0354","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"1493_CR47","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals\u00a0M, Brito-Zer\u00f3n\u00a0P, Bombardieri\u00a0S et\u00a0al (2020) EULAR recommendations for the management of sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis 79(1):3\u201318. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216114","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1493_CR48","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10067-019-04724-w","volume":"39","author":"AC Machado","year":"2020","unstructured":"Machado\u00a0AC, Dos Santos\u00a0LC, Fidelix\u00a0T et\u00a0al (2020) Effectiveness and safety of abatacept for the treatment of patients with primary sj\u00f6gren\u2019s syndrome. Clin Rheumatol 39(1):243\u2013248. https:\/\/doi.org\/10.1007\/s10067-019-04724-w","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1493_CR49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/annrheumdis-2020-218599","volume":"80","author":"AN Baer","year":"2021","unstructured":"Baer\u00a0AN, Gottenberg\u00a0J, Clair\u00a0StEW et\u00a0al (2021) Efficacy and safety of abatacept in active primary sj\u00f6gren\u2019s syndrome: Results of a\u00a0phase\u00a0III, randomised, placebo-controlled trial. Ann Rheum Dis 80(3):339\u2013348. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218599","journal-title":"Ann Rheum Dis"},{"issue":"10320","key":"1493_CR50","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0140-6736(21)02251-0","volume":"399","author":"SJ Bowman","year":"2022","unstructured":"Bowman\u00a0SJ, Fox\u00a0R, D\u00f6rner\u00a0T et\u00a0al (2022) Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary sj\u00f6gren\u2019s syndrome: A\u00a0randomised, double-blind, placebo-controlled, phase\u00a02b dose-finding trial. Lancet 399(10320):161\u2013171. https:\/\/doi.org\/10.1016\/S0140-6736(21)02251-0","journal-title":"Lancet"},{"issue":"4","key":"1493_CR51","first-page":"222","volume":"38 Suppl 126","author":"E Pontarini","year":"2020","unstructured":"Pontarini\u00a0E, Verstappen\u00a0GM, Grigoriadou\u00a0S, Kroese\u00a0FGM, Bootsma\u00a0H, Bombardieri\u00a0M (2020) Blocking T\u00a0cell co-stimulation in primary sj\u00f6gren\u2019s syndrome: Rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers. Clin Exp Rheumatol 38 Suppl 126(4):222\u2013227","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"1493_CR52","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"MI Christodoulou","year":"2010","unstructured":"Christodoulou\u00a0MI, Kapsogeorgou\u00a0EK, Moutsopoulos\u00a0HM (2010) Characteristics of the minor salivary gland infiltrates in sj\u00f6gren\u2019s syndrome. J\u00a0Autoimmun 34(4):400\u2013407. https:\/\/doi.org\/10.1016\/j.jaut.2009.10.004","journal-title":"J Autoimmun"},{"key":"1493_CR53","unstructured":"Benjamin Fisher A, Xavier M, Athena Papas S et\u00a0al (2023) Iscalimab (CFZ533) in patients with sj\u00f6gren\u2019s disease: Week 24 efficacy and safety results of a\u00a0randomized, placebo-controlled, phase\u00a02b dose-ranging study. 75(suppl 9) (2023)"},{"key":"1493_CR54","unstructured":"St. William Clair E, Liangwei W, Ilias A et\u00a0al (2023) Dazodalibep, a\u00a0CD40L antagonist, in subjects with sj\u00f6gren\u2019s having moderate-to-severe systemic disease activity: Full crossover results from a\u00a0phase\u00a02, randomized, double-blind, placebo-controlled, proof of concept study. Arthritis Rheumatol 75(Suppl 9)"},{"issue":"23","key":"1493_CR55","doi-asserted-by":"publisher","first-page":"e163030","DOI":"10.1172\/jci.insight.163030","volume":"7","author":"X Mariette","year":"2022","unstructured":"Mariette\u00a0X, Barone\u00a0F, Baldini\u00a0C et\u00a0al (2022) A\u00a0randomized, phase\u00a0II study of sequential belimumab and rituximab in primary sj\u00f6gren\u2019s syndrome. JCI Insight 7(23):e163030. https:\/\/doi.org\/10.1172\/jci.insight.163030","journal-title":"JCI Insight"},{"issue":"1","key":"1493_CR56","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/14397595.2019.1707996","volume":"31","author":"Y Liu","year":"2021","unstructured":"Liu\u00a0Y, Li\u00a0C, Wang\u00a0S et\u00a0al (2021) Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in sj\u00f6gren\u2019s syndrome by inducing regulatory T\u00a0cells. Mod Rheumatol 31(1):186\u2013196. https:\/\/doi.org\/10.1080\/14397595.2019.1707996","journal-title":"Mod Rheumatol"},{"issue":"10416","key":"1493_CR57","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/S0140-6736(23)01126-1","volume":"402","author":"G Schett","year":"2023","unstructured":"Schett\u00a0G, Mackensen\u00a0A, Mougiakakos\u00a0D (2023) CAR T\u2011cell therapy in autoimmune diseases. Lancet 402(10416):2034\u20132044. https:\/\/doi.org\/10.1016\/S0140-6736(23)01126-1","journal-title":"Lancet"},{"issue":"7","key":"1493_CR58","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/annrheumdis-2021-222054","volume":"81","author":"R Seror","year":"2022","unstructured":"Seror\u00a0R, Baron\u00a0G, Camus\u00a0M et\u00a0al (2022) Development and preliminary validation of the sj\u00f6gren\u2019s tool for assessing response (STAR): A\u00a0consensual composite score for assessing treatment effect in primary sj\u00f6gren\u2019s syndrome. Ann Rheum Dis 81(7):979\u2013989. https:\/\/doi.org\/10.1136\/annrheumdis-2021-222054","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1493_CR59","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/S2665-9913(21)00122-3","volume":"3","author":"S Arends","year":"2021","unstructured":"Arends\u00a0S, de Wolff\u00a0L, van Nimwegen\u00a0JF et\u00a0al (2021) Composite of relevant endpoints for sj\u00f6gren\u2019s syndrome (CRESS): Development and validation of a\u00a0novel outcome measure. Lancet Rheumatol 3(8):e553\u2013e562. https:\/\/doi.org\/10.1016\/S2665-9913(21)00122-3","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"1493_CR60","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00005792-200207000-00004","volume":"81","author":"M Ramos-Casals","year":"2002","unstructured":"Ramos-Casals\u00a0M, Font\u00a0J, Garcia-Carrasco\u00a0M et\u00a0al (2002) Primary sj\u00f6gren syndrome: Hematologic patterns of disease expression. Medicine 81(4):281\u2013292. https:\/\/doi.org\/10.1097\/00005792-200207000-00004","journal-title":"Medicine"},{"key":"1493_CR61","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3389\/fmed.2018.00102","volume":"5","author":"A Alunno","year":"2018","unstructured":"Alunno\u00a0A, Leone\u00a0MC, Giacomelli\u00a0R, Gerli\u00a0R, Carubbi\u00a0F (2018) Lymphoma and lymphomagenesis in primary sj\u00f6gren\u2019s syndrome. Front Med 5:102. https:\/\/doi.org\/10.3389\/fmed.2018.00102","journal-title":"Front Med"},{"issue":"3","key":"1493_CR62","first-page":"113","volume":"36 Suppl 112","author":"E Bartoloni","year":"2018","unstructured":"Bartoloni\u00a0E, Alunno\u00a0A, Valentini\u00a0V et\u00a0al (2018) The prevalence and relevance of traditional cardiovascular risk factors in primary sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol 36 Suppl 112(3):113\u2013120","journal-title":"Clin Exp Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-024-01493-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-024-01493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:05:51Z","timestamp":1711548351000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-024-01493-z"}},"subtitle":["Diagnostik, Therapie und Fallstricke","Diagnostics, treatment, and challenges"],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1007\/s00393-024-01493-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]},"assertion":[{"value":"26 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>N.\u00a0Zehrfeld<\/b>: A.\u00a0Finanzielle Interessen: N.\u00a0Zehrfeld gibt an, dass kein finanzieller Interessenkonflikt besteht. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Studentin der Humanmedizin, Medizinische Hochschule Hannover (2017\u2013vvrs. 2025); Promotionsprojekt im KlinStrucMed-Kolleg der Hannover Biomedical Research School, gef\u00f6rdert durch die Else-Kr\u00f6ner-Fresenius-Stiftung (2021\u20132022) in der AG Ernst zur Pr\u00e4valenz von Atherosklerose bei prim\u00e4rem Sj\u00f6gren-Syndrom; wissenschaftliche T\u00e4tigkeit in der AG Ernst, studienbegleitend seit 2021; Stipendiatin in der Studienstiftung des deutschen Volkes (seit 01\/2018); ehrenamtliche T\u00e4tigkeit im Bev\u00f6lkerungsschutz der Malteser Hannover (10\/2019). <b>T.\u00a0Witte<\/b>: A.\u00a0Finanzielle Interessen: Novartis (f\u00fcr RFA), Takeda (f\u00fcr Materialien).\u00a0\u2013 F\u00fcr Vortr\u00e4ge von Abbvie, Alexion, AstraZeneca, BMS, Chugai, Galapagos, GSK, Lilly, Novartis, Pfizer, Roche, Sanofi, Takeda, UCB, Viatris. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: Direktor der Klink f\u00fcr Rheumatologie und Immunologie, Med. Hochschule Hannover | Mitgliedschaften: DGRh; DGfl. <b>D.\u00a0Ernst<\/b>: A.\u00a0Finanzielle Interessen: Kongresskosten\u00fcbernahmen von Abbvie, BMS, Pfizer | Referentenhonorare: Abbvie, Amgen, Galapagos, GSK, Medac, Novartis.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Niedergelassene Internistin Rheumatologische Facharztpraxis, Hannover, Deutschland | Angestellte Ober\u00e4rztin, Klinik f\u00fcr Rheumatologie und Immunologie, Medizinische Hochschule Hannover | Mitgliedschaften: DGRh; BDRh | BDRh Vorstand.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}